Although increasing evidence has shown that activation of the AMH‐AMHR2 pathway leads to cell cycle delays not only in gynecological cancers but also in several non‐gynecological cancers,13, 43, 44 it is still uncertain at what point in the cell cycle this pathway acts upon. The gene discussed is AMH; the disease is female reproductive organ cancer.